Key result
Structured four-phase approach guides management of hemodynamically stable wide QRS complex tachycardia in ICD patients.
Why the study?
Managing hemodynamically stable, incessant wide QRS complex tachycardia in patients with an ICD is challenging, particularly for first-line staff unfamiliar with device settings who face concerns about unexpected shocks.
This review provides a structured, four-phase clinical pathway for managing hemodynamically stable wide QRS complex tachycardia in patients with ICDs.
May guide management of stable wide QRS tachycardia in ICD patients; leaves open prospective validation.
Management of hemodynamically stable, incessant wide QRS complex tachycardia (WCT) in patients who already have an implantable cardioverter defibrillator (ICD) is challenging. First-line treatment is performed by medical staff who have no knowledge on programmed ICD therapy settings and there is always some concern for unexpected ICD shock. In these patients, a structured approach is necessary from presentation to therapy. The present review provides a systematic approach in four distinct phases to guide any physician involved in the management of these patients: PHASE I: assessment of hemodynamic status and use of the magnet to temporarily suspend ICD therapies, especially shocks; identification of possible arrhythmia triggers; risk stratification in case of electrical storm (ES). PHASE II: The preparation phase includes reversal of potential arrhythmia "triggers", mild patient sedation, and patient monitoring for therapy delivery. Based on resource availability and competences, the most adequate therapeutic approach is chosen. This choice depends on whether a device specialist is readily available or not. In the case of ES in a "high-risk" patient an accelerated patient management protocol is advocated, which considers urgent ventricular tachycardia transcatheter ablation with or without mechanical cardiocirculatory support. PHASE III: Therapeutic phase is based on the use of intravenous anti-arrhythmic drugs mostly indicated in this clinical context are presented. Device interrogation is very important in this phase when sustained monomorphic VT diagnosis is confirmed, then ICD ATP algorithms, based on underlying VT cycle length, are proposed. In high-risk patients with intractable ES, intensive patient management considers MCS and transcatheter ablation. PHASE IV: The patient is hospitalized for further diagnostics and management aimed at preventing arrhythmia recurrences.
No takes yet. Share an insight, caveat, or question.
Regoli et al. (2023) conducted a review in Hemodynamically stable wide QRS complex tachycardia in patients with implantable cardioverter defibrillators. Structured four-phase management approach was evaluated. A structured four-phase approach, including magnet application, ICD interrogation, and anti-tachycardia pacing, is recommended for managing hemodynamically stable wide QRS complex tachycardia in ICD patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: